Contract

NHS National Framework for Transition products (Axitinib and Eltrombopag)

  • NHS England

UK7: Contract details notice - Procurement Act 2023 - view information about notice types

Notice identifier: 2025/S 000-054095

Procurement identifier (OCID): ocds-h6vhtk-050bb9 (view related notices)

Published 4 September 2025, 5:47pm



Scope

Reference

C357509

Description

Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025

Offer reference number: CM/TNS/25/5722

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months.

Potential periods of call-offs under the framework agreement:

CM/TNS/25/5722/01 Axitinib and Eltrombopag

Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months)

Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months)

Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.

Commercial tool

Establishes a framework


Framework

Maximum percentage fee charged to suppliers

0%

Framework operation description

Please refer to the ITO Documents for the Operation Description

Award method when using the framework

With competition

Contracting authorities that may use the framework

Establishing party only


Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

Suppliers (7)

Contract value

  • £52,385,000 excluding VAT
  • £62,862,000 including VAT

Above the relevant threshold

Date signed

18 August 2025

Contract dates

  • 1 October 2025 to 31 January 2027
  • Possible extension to 30 September 2029
  • 4 years

Description of possible extension:

option or options to extend (at the discretion of the Authority) up to maximum of 48 months.

Main procurement category

Goods

CPV classifications

  • 33600000 - Pharmaceutical products

Signed contract documents

CONTRACT COPY - Combined Documents - Contract Details Notice CM-TNS-25-5722.pdf


Other information

Applicable trade agreements

  • Government Procurement Agreement (GPA)

Conflicts assessment prepared/revised

Yes


Procedure

Procedure type

Open procedure


Suppliers

DR REDDY'S LABORATORIES (UK) LIMITED

  • Companies House: 01729064

410 Cambridge Science Park Milton Road

Cambridge

CB4 0PE

United Kingdom

Region: UKH12 - Cambridgeshire CC

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

NOVARTIS PHARMACEUTICALS UK LIMITED

  • Companies House: 00119006

2nd Floor, The Westworks Building White City Place

London

W12 7FQ

United Kingdom

Region: UKI33 - Kensington & Chelsea and Hammersmith & Fulham

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

PERENNIAL PHARMA LTD

  • Companies House: 11826246

2nd Floor Titan Court

Hatfield

AL10 9NA

United Kingdom

Region: UKH23 - Hertfordshire

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

PFIZER LIMITED

  • Companies House: 00526209

Pfizer Limited, Ramsgate Road

Kent

CT13 9NJ

United Kingdom

Region: UKJ44 - East Kent

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

TEVA UK LIMITED

  • Companies House: 00302461

Ridings Point

Castleford

WF10 5HX

United Kingdom

Region: UKE45 - Wakefield

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

THORNTON & ROSS LIMITED

  • Companies House: 00185947

Linthwaite Labs Manchester Road

Huddersfield

HD7 5QH

United Kingdom

Region: UKE44 - Calderdale and Kirklees

Small or medium-sized enterprise (SME): No

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)

WOCKHARDT UK LIMITED

  • Companies House: 05835570

Ash Road North

Wrexham

LL13 9UF

United Kingdom

Region: UKL23 - Flintshire and Wrexham

Small or medium-sized enterprise (SME): Yes

Voluntary, community or social enterprise (VCSE): No

Supported employment provider: No

Public service mutual: No

Contract 1. NHS National Framework for Transition products (Axitinib and Eltrombopag)


Contracting authority

NHS England

  • Public Procurement Organisation Number: PDPT-3135-BWWY

7&8 Wellington Place

Leeds

LS1 4AP

United Kingdom

Contact name: Katie Noonan

Email: katie.noonan@nhs.net

Website: https://www.england.nhs.uk//

Region: UKE42 - Leeds

Organisation type: Public authority - central government